TRINITY BIOTECH PLC (TRIB) research
TRINITY BIOTECH PLC- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $5.69
- As of
TRINITY BIOTECH PLC (TRIB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-09.
As of . Source: SEC EDGAR filings for TRIB. Method and limitations.
Share the TRIB intelligence card
See the full TRIB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TRIB on one page. Preview it with sample data, then open it live with a free account.
Preview the TRIB dossierActive signals for TRIB
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 84% of TRIB (2026Q1)
- mediumNEW_POSITION
D. E. Shaw & Co., Inc. new position in TRIB
- highINSTITUTIONAL_SURGE
TWO SIGMA INVESTMENTS, LP added +125% to TRIB (2026Q1)
- mediumEARNINGS_MISS
Q2-2024: Missed consensus by 7.7% - EPS $-0.714 vs $-0.663 estimate
- mediumEARNINGS_MISS
Q4-2024: Missed consensus by 272.5% - EPS $-1.14 vs $-0.306 estimate
FREE, NO ACCOUNT
Every signal on TRIB, as it fires
You are seeing 5 of 9 signals recorded on TRIB since 2026-05-24.
The five above landed across 2 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, TRIB
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
TRIB against its peers
TRIB's operating margin of -34.4% ranks in the 79th percentile of 6 Medical Devices sub-industry peers, fiscal periods ending between 2024-09-30 and 2025-05-31.
| Metric | TRIB | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 61.6M USD | 2.5M USD | 94 | 8 |
| Revenue YoY | 8.3% | n/a | n/a | 1 |
| Gross margin | 34.8% | 37.4% | 44 | 7 |
| Operating margin | -34.4% | -134.3% | 79 | 6 |
| Net margin | -50.7% | -120.5% | 72 | 8 |
| Return on equity | n/a | -73.8% | n/a | 6 |
Peers (9): ITOC, STME, SONX, ICCM, WOK, TANAF, POAS, BMRA, ALRTF. Left out: INBS (period gap), AIDX (period gap), KLYG (no annual filing), NVNO (period gap), USAQ (period gap), AEMD (period gap), VNRX (period gap), PMEDF (period gap), AMIX (period gap), CODX (period gap), ADGM (period gap), NXL (period gap), PMI (period gap), IRIX (period gap), VVOS (period gap), CYDX (no annual filing). Fiscal periods ending between 2024-09-30 and 2025-05-31. Every figure is one full fiscal year read from one annual filing (TRIB: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more TRIB signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to TRIBand get the insider, 13F, options, and confluence read in one view.